Stocks · Health care · Services-General Medical & Surgical Hospitals, NEC

TENET HEALTHCARE CORP

THC Clue Score49
United States Fiscal year ends December CIK 0000070318 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Daniel J Cancelmi
26 Oct 2022
EVP & Chief Financial Officer
Buy
11,000
$43.07
$473.77K
Meghan Fitzgerald
17 Mar 2020
Director
Buy
6,153
$13.02
$80.11K
Marie Quintana
16 Mar 2020
EVP, Marketing/Communications
Buy
2,596
$14.75
$38.29K
Nadja West
16 Mar 2020
Director
Buy
1,000
$15.42
$15.42K
Paola M Arbour
16 Mar 2020
EVP, Chief Information Officer
Buy
2,560
$14.79
$37.86K
Saumya Sutaria
16 Mar 2020
President & COO
Buy
20,000
$17.28
$345.60K
Daniel J Cancelmi
13 Mar 2020
EVP & Chief Financial Officer
Buy
19,220
$15.79
$303.48K
Ronald A Rittenmeyer
13 Mar 2020
Executive Chairman and CEO
Buy
11,500
$17.18
$197.57K
Ronald A Rittenmeyer
2 Mar 2020
Executive Chairman and CEO
Buy
10,000
$27.11
$271.10K
Glenview Capital Management, LLC
3 Oct 2019
10% owner
Buy indirect
39,665
$20.50
$813.09K
Glenview Capital Management, LLC
2 Oct 2019
10% owner
Buy indirect
221,875
$20.50
$4.55M
Glenview Capital Management, LLC
6 Sep 2019
10% owner
Buy indirect
8,160
$19.65
$160.31K
Glenview Capital Management, LLC
23 Aug 2019
10% owner
Buy indirect
81,368
$20.70
$1.68M
Glenview Capital Management, LLC
16 Aug 2019
10% owner
Buy indirect
26,456
$19.82
$524.23K
Glenview Capital Management, LLC
15 Aug 2019
10% owner
Buy indirect
150,107
$19.34
$2.90M
Glenview Capital Management, LLC
14 Aug 2019
10% owner
Buy indirect
2,953
$20.58
$60.77K
Glenview Capital Management, LLC
14 Aug 2019
10% owner
Buy indirect
287,486
$19.94
$5.73M
Glenview Capital Management, LLC
13 Aug 2019
10% owner
Buy indirect
173,235
$21.09
$3.65M
Glenview Capital Management, LLC
26 Jul 2019
10% owner
Buy indirect
27,424
$20.99
$575.63K
Glenview Capital Management, LLC
25 Jul 2019
10% owner
Buy indirect
600,000
$19.64
$11.78M
Glenview Capital Management, LLC
24 Jul 2019
10% owner
Buy indirect
200,000
$19.36
$3.87M
Ronald A Rittenmeyer
11 Nov 2016
Director
Buy indirect
15,000
$14.35
$215.25K
Peter M Wilver
9 Nov 2016
Director
Buy
5,000
$15.19
$75.95K

What was left out

Form 4 filings counted 458
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 22
Sales at will 157
Transactions with no price 0
Shares from compensation/vesting 8,810,943
Sales filed before the plan box existed 57
History held since 3 Oct 2006